A Twist in the Fibrotic Tale: The Overlooked Vasculopathy in Idiopathic Pulmonary Fibrosis.
作者信息
Tonelli Adriano R, Sahay Sandeep
机构信息
Integrated Hospital Care Institute Cleveland Clinic Cleveland, Ohio.
Division of Pulmonary, Critical Care, and Sleep Medicine Houston Methodist Hospital Houston, Texas.
出版信息
Am J Respir Crit Care Med. 2025 Jun;211(6):897-898. doi: 10.1164/rccm.202502-0465ED.
Abstract
摘要
相似文献
1
A Twist in the Fibrotic Tale: The Overlooked Vasculopathy in Idiopathic Pulmonary Fibrosis.纤维化故事中的一个转折：特发性肺纤维化中被忽视的血管病变
Am J Respir Crit Care Med. 2025 Jun;211(6):897-898. doi: 10.1164/rccm.202502-0465ED.
2
A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin.基于博来霉素诱导的优化肺纤维化小鼠模型所开发的、利用微型计算机断层扫描（Micro-CT）图像的一种新型肺纤维化量化方法。
Heliyon. 2023 Feb 10;9(3):e13598. doi: 10.1016/j.heliyon.2023.e13598. eCollection 2023 Mar.
3
Ugonin L ameliorates pulmonary fibrosis as a novel TβRs inhibitor by regulating the TGF-β/TβRs signaling and autophagy.乌戈宁L作为一种新型的TβRs抑制剂，通过调节TGF-β/TβRs信号传导和自噬来改善肺纤维化。
Biomed Pharmacother. 2025 Jun 17;189:118267. doi: 10.1016/j.biopha.2025.118267.
4
Alveolar epithelial disintegrity in pulmonary fibrosis.肺纤维化中的肺泡上皮完整性破坏
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L185-91. doi: 10.1152/ajplung.00115.2016. Epub 2016 May 27.
5
NARI-29: A Novel Epalrestat Derivative Attenuates Pulmonary Fibrosis by Modulating the TGF-β/Smad Signaling.NARI-29：一种新型依帕司他衍生物通过调节转化生长因子-β/信号转导和转录激活因子信号通路减轻肺纤维化。
ACS Pharmacol Transl Sci. 2025 May 9;8(6):1610-1626. doi: 10.1021/acsptsci.5c00009. eCollection 2025 Jun 13.
6
Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis or emphysema alone.合并肺纤维化和肺气肿的肺动脉高压相关血管病变的组织学分析：与单纯特发性肺纤维化或肺气肿的比较
Histopathology. 2017 May;70(6):896-905. doi: 10.1111/his.13153. Epub 2017 Feb 8.
7
MHCIILYVE1CCR2 Interstitial Macrophages Promote Medial Fibrosis in Pulmonary Arterioles and Contribute to Pulmonary Hypertension.MHCIILYVE1CCR2间质巨噬细胞促进肺小动脉的内侧纤维化并导致肺动脉高压。
Circ Res. 2025 Jun 20;137(1):46-66. doi: 10.1161/CIRCRESAHA.125.326173. Epub 2025 May 13.
8
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating mA-regulated expression of a novel anti-fibrotic target ETV4.猪去氧胆酸通过促进由 mA 调控的新型抗纤维化靶点 ETV4 的表达来改善胆汁淤积性肝纤维化。
J Hepatol. 2025 Feb 4. doi: 10.1016/j.jhep.2025.01.020.
9
Targeting Senescent Alveolar Type 2 Cells with a Gene-Editable FePt Dual-Atom Catalyst for Mitigating Idiopathic Pulmonary Fibrosis.使用基因可编辑的FePt双原子催化剂靶向衰老的肺泡II型细胞以减轻特发性肺纤维化
ACS Nano. 2025 Jul 1;19(25):23162-23176. doi: 10.1021/acsnano.5c04686. Epub 2025 Jun 18.
10
Characterization of Aortic Valve Stenosis by CT Angiography in a Diverse US Cohort.美国不同人群中CT血管造影对主动脉瓣狭窄的特征分析
Circ Cardiovasc Imaging. 2025 Jun;18(6):e017858. doi: 10.1161/CIRCIMAGING.124.017858. Epub 2025 May 9.
本文引用的文献
1
Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant.等待肺移植的特发性肺纤维化患者的系列肺血流动力学研究
Am J Respir Crit Care Med. 2025 Jun;211(6):984-991. doi: 10.1164/rccm.202411-2157OC.
2
Factors Associated With High Intrathoracic Pressure in Patients With Obesity Undergoing Right Heart Catheterization.
Chest. 2025 Jun;167(6):1759-1763. doi: 10.1016/j.chest.2024.12.034. Epub 2025 Jan 11.
3
Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease.吸入性曲前列尼尔治疗肺动脉高压-间质性肺病的疗效和反应决定因素。
Respir Med. 2024 Nov-Dec;234:107835. doi: 10.1016/j.rmed.2024.107835. Epub 2024 Oct 18.
4
Definition, classification and diagnosis of pulmonary hypertension.肺动脉高压的定义、分类和诊断。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01324-2024. Print 2024 Oct.
5
Pulmonary hypertension associated with lung diseases.与肺部疾病相关的肺动脉高压。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01200-2024. Print 2024 Oct.
6
Impact on Pulmonary Hypertension Hemodynamic Classification Based on the Methodology Used to Measure Pulmonary Artery Wedge Pressure and Cardiac Output.基于测量肺动脉楔压和心输出量的方法对肺动脉高压血流动力学分类的影响。
Ann Am Thorac Soc. 2023 Dec;20(12):1752-1759. doi: 10.1513/AnnalsATS.202303-216OC.
7
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
8
Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.肺动脉高压中不同心脏指数估算方法的比较
Circulation. 2019 Aug 20;140(8):705-707. doi: 10.1161/CIRCULATIONAHA.119.041614. Epub 2019 Aug 19.
9
Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction.特发性肺纤维化合并轻中度限制的平均肺动脉压进展。
Respirology. 2017 Jul;22(5):986-990. doi: 10.1111/resp.12986. Epub 2017 Jan 24.
10
Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.特发性肺纤维化中肺动脉高压的无创筛查
Respir Med. 2016 Aug;117:65-72. doi: 10.1016/j.rmed.2016.06.001. Epub 2016 Jun 2.
Zotero 插件